Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385706892> ?p ?o ?g. }
- W4385706892 abstract "Bevacizumab (Bev) plus chemotherapy is a standard first-line treatment in metastatic colorectal cancer (mCRC), however to date no predictive factors of response have been identified. Results of our previous analysis on patients enrolled in a randomized prospective phase III multicenter study (ITACa study) showed a predictive value of Vascular Endothelial Growth Factor (VEGF) polymorphism (VEGF + 936), a 27-nucleotide variable number tandem repeat (VNTR) of the endothelial nitric oxide synthase (eNOS) gene and eNOS + 894 polymorphism. mCRC patients, treated with Bev plus chemotherapy, were included in this prospective validation trial. eNOS + 894G > T was analyzed by Real time PCR, while the eNOS VNTR and VEGF + 936C > T were determined by standard PCR and direct sequencing analysis. These polymorphisms were assessed in relation to progression-free survival (PFS), overall survival (OS) and objective response rate (ORR). These three polymorphisms were not predictive of PFS (p 0.91, 0.59 and 0.09, respectively), and OS (p 0.95, 0.32 and 0.46, respectively). Moreover, the haplotype analyses did not confirm what was found in our previous study; patients bearing a specific haplotype of eNOS had not significantly improved outcomes. This prospective study failed to validate the predictive impact of eNOS and VEGF polymorphisms for response to Bev plus first-line chemotherapy in mCRC patients." @default.
- W4385706892 created "2023-08-10" @default.
- W4385706892 creator A5004801731 @default.
- W4385706892 creator A5005089413 @default.
- W4385706892 creator A5020410493 @default.
- W4385706892 creator A5021298702 @default.
- W4385706892 creator A5036936997 @default.
- W4385706892 creator A5039708520 @default.
- W4385706892 creator A5051783457 @default.
- W4385706892 creator A5058164461 @default.
- W4385706892 creator A5061508525 @default.
- W4385706892 creator A5067535594 @default.
- W4385706892 creator A5069544292 @default.
- W4385706892 creator A5082044251 @default.
- W4385706892 creator A5084691460 @default.
- W4385706892 creator A5086579812 @default.
- W4385706892 creator A5087670194 @default.
- W4385706892 date "2023-08-09" @default.
- W4385706892 modified "2023-10-16" @default.
- W4385706892 title "Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer" @default.
- W4385706892 cites W1900204802 @default.
- W4385706892 cites W1954343133 @default.
- W4385706892 cites W1963832292 @default.
- W4385706892 cites W1998500745 @default.
- W4385706892 cites W2019367792 @default.
- W4385706892 cites W2029639823 @default.
- W4385706892 cites W2035620169 @default.
- W4385706892 cites W2068411944 @default.
- W4385706892 cites W2077884273 @default.
- W4385706892 cites W2086706326 @default.
- W4385706892 cites W2108923962 @default.
- W4385706892 cites W2115735904 @default.
- W4385706892 cites W2125447919 @default.
- W4385706892 cites W2131705241 @default.
- W4385706892 cites W2139996974 @default.
- W4385706892 cites W2140578526 @default.
- W4385706892 cites W2144024299 @default.
- W4385706892 cites W2147834058 @default.
- W4385706892 cites W2149254095 @default.
- W4385706892 cites W2150616706 @default.
- W4385706892 cites W2157769714 @default.
- W4385706892 cites W2159034771 @default.
- W4385706892 cites W2160920221 @default.
- W4385706892 cites W2341272418 @default.
- W4385706892 cites W2588033918 @default.
- W4385706892 cites W3128646645 @default.
- W4385706892 cites W4322719806 @default.
- W4385706892 doi "https://doi.org/10.1038/s41598-023-40220-7" @default.
- W4385706892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37558720" @default.
- W4385706892 hasPublicationYear "2023" @default.
- W4385706892 type Work @default.
- W4385706892 citedByCount "0" @default.
- W4385706892 crossrefType "journal-article" @default.
- W4385706892 hasAuthorship W4385706892A5004801731 @default.
- W4385706892 hasAuthorship W4385706892A5005089413 @default.
- W4385706892 hasAuthorship W4385706892A5020410493 @default.
- W4385706892 hasAuthorship W4385706892A5021298702 @default.
- W4385706892 hasAuthorship W4385706892A5036936997 @default.
- W4385706892 hasAuthorship W4385706892A5039708520 @default.
- W4385706892 hasAuthorship W4385706892A5051783457 @default.
- W4385706892 hasAuthorship W4385706892A5058164461 @default.
- W4385706892 hasAuthorship W4385706892A5061508525 @default.
- W4385706892 hasAuthorship W4385706892A5067535594 @default.
- W4385706892 hasAuthorship W4385706892A5069544292 @default.
- W4385706892 hasAuthorship W4385706892A5082044251 @default.
- W4385706892 hasAuthorship W4385706892A5084691460 @default.
- W4385706892 hasAuthorship W4385706892A5086579812 @default.
- W4385706892 hasAuthorship W4385706892A5087670194 @default.
- W4385706892 hasBestOaLocation W43857068921 @default.
- W4385706892 hasConcept C121608353 @default.
- W4385706892 hasConcept C126322002 @default.
- W4385706892 hasConcept C143998085 @default.
- W4385706892 hasConcept C167734588 @default.
- W4385706892 hasConcept C188816634 @default.
- W4385706892 hasConcept C2776694085 @default.
- W4385706892 hasConcept C2777025900 @default.
- W4385706892 hasConcept C2777622882 @default.
- W4385706892 hasConcept C2777802072 @default.
- W4385706892 hasConcept C2778326061 @default.
- W4385706892 hasConcept C519581460 @default.
- W4385706892 hasConcept C526805850 @default.
- W4385706892 hasConcept C71924100 @default.
- W4385706892 hasConcept C90924648 @default.
- W4385706892 hasConceptScore W4385706892C121608353 @default.
- W4385706892 hasConceptScore W4385706892C126322002 @default.
- W4385706892 hasConceptScore W4385706892C143998085 @default.
- W4385706892 hasConceptScore W4385706892C167734588 @default.
- W4385706892 hasConceptScore W4385706892C188816634 @default.
- W4385706892 hasConceptScore W4385706892C2776694085 @default.
- W4385706892 hasConceptScore W4385706892C2777025900 @default.
- W4385706892 hasConceptScore W4385706892C2777622882 @default.
- W4385706892 hasConceptScore W4385706892C2777802072 @default.
- W4385706892 hasConceptScore W4385706892C2778326061 @default.
- W4385706892 hasConceptScore W4385706892C519581460 @default.
- W4385706892 hasConceptScore W4385706892C526805850 @default.
- W4385706892 hasConceptScore W4385706892C71924100 @default.
- W4385706892 hasConceptScore W4385706892C90924648 @default.
- W4385706892 hasIssue "1" @default.
- W4385706892 hasLocation W43857068921 @default.
- W4385706892 hasLocation W43857068922 @default.